Royalty Pharma PLC
F:RPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Royalty Pharma PLC
F:RPD
|
US |
|
5
|
5E Advanced Materials Inc
ASX:5EA
|
US |
|
Repligen Corp
NASDAQ:RGEN
|
US |
|
A
|
ASOS PLC
F:DYQ
|
UK |
|
K
|
Karman Holdings Inc
NYSE:KRMN
|
US |
|
Hino Motors Ltd
TSE:7205
|
JP |
Wall St Price Targets
RPD Price Targets Summary
Royalty Pharma PLC
According to Wall Street analysts, the average 1-year price target for RPD is 32.34 EUR with a low forecast of 25.74 EUR and a high forecast of 38.39 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RPD's stock price target?
Price Target
32.34
EUR
According to Wall Street analysts, the average 1-year price target for RPD is 32.34 EUR with a low forecast of 25.74 EUR and a high forecast of 38.39 EUR.
What is the Revenue forecast for Royalty Pharma PLC?
Projected CAGR
16%
Over the last 7 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 16%.
What is the Operating Income forecast for Royalty Pharma PLC?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Royalty Pharma PLC?
Projected CAGR
31%
Over the last 7 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 7 years is 31%.
